CVS Health Publishes Q3 2026 Earnings Call Transcript

By Public Technologies
  • CVS Health plans to split into two publicly traded companies, separating retail pharmacy from healthcare solutions in the first half of 2028.
  • The November 4, 2026, third-quarter earnings call featured CEO J. David Joyner, CFO Brian O. Newman and other executives.
  • The healthcare solutions business will retain Aetna, Caremark and specialty pharmacy; CVS Pharmacy will include retail stores, mail order and community healthcare.
  • Management raised 2026 adjusted EPS guidance to at least $8.20 from $7.90-$8.10; operating cash flow is forecast at least $15.5 billion.
  • The 2027 adjusted EPS outlook is at least $8.65; share repurchases will resume in the fourth quarter of 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.